Search

everythinglearnresearchcommunity

for

Search:↓

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Upadacitinib improved multiple immune-related conditions in one patient.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Omalizumab may cause hair loss.

A woman with a rare autoimmune disorder had a blister on her eye and unique immune reaction, which was effectively treated with medication.

A patient with a PLEC mutation has epidermolysis bullosa, muscular dystrophy, and myasthenia gravis, which improved with steroid treatment.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Anifrolumab effectively improved symptoms and reduced steroid use in Japanese patients with systemic lupus erythematosus.

Dupilumab may cause significant hair loss, which can reverse after stopping the drug.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.

Dupilumab improves skin microbiome balance in atopic dermatitis patients.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Alopecia universalis from alemtuzumab in multiple sclerosis can be reversed with specific treatments.

Vemurafenib can cause scalp issues but can be managed without changing the dose.

A Labrador Retriever with pemphigus fully recovered after six weeks of azathioprine treatment.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Pimecrolimus reduces the effectiveness of stem cell therapy for atopic dermatitis.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Dupilumab can improve both atopic dermatitis and alopecia universalis.

Dupilumab effectively treats severe skin issues in a rare genetic disorder.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.